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Objective. Newly presented unexplained complaints (UCs) are common in general practice.
Factors influencing the transition of newly presented into persistent UCs have been scarcely
investigated. We studied the number and the nature of diagnoses made over time, as well as fac-
tors associated with UCs becoming persistent. Finally, we longitudinally studied factors associ-
ated with quality of life (QoL).
Methods. Prospective cohort study in general practice of patients presenting with a new UC. Data
sources were case record forms, patient questionnaires and electronic medical registries at inclu-
sion, 1, 6 and 12 months. Presence of complaints and diagnoses made over time were docu-
mented. Potential risk factors were assessed in mixed-effect logistic and linear regression models.
Results. Sixty-three GPs included 444 patients (73% women; median age 42) with unexplained
fatigue (70%), abdominal complaints (14%) and musculoskeletal complaints (16%). At 12 months,
43% of the patients suffered from their initial complaints. Fifty-seven percent of the UCs remained
unexplained. UCs had (non-life-threatening) somatic origins in 18% of the patients. QoL was often
poor at presentation and tended to remain poor. Being a male [odds ratio (OR) 0.6; 95% confidence
interval (CI) 0.4–0.8] and GPs’ being more certain about the absence of serious disease (OR 0.9;
95% CI 0.8–0.9) were the strongest predictors of a diminished probability that the complaints
would still be present and unexplained after 12 months. The strongest determinants of complaint
persistence [regardless of (un)explicability] were duration of complaints >4 weeks before presen-
tation (OR 2.6; 95% CI 1.6–4.3), musculoskeletal complaint at baseline (OR 2.3; 1.2–4.5), while the
passage of time acted positively (OR 0.8 per month; 95% CI 0.78–0.84). Musculoskeletal com-
plaints, compared to fatigue, decreased QoL on the physical domain (4.6 points; 2.6–6.7), while
presence of psychosocial factors decreased mental QoL (5.0; 3.1–6.9).
Conclusion. One year after initial presentation, a large proportion of newly presented UCs
remained unexplained and unresolved. We identified determinants that GPs might want to con-
sider in the early detection of patients at risk of UC persistence and/or low QoL.
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Introduction
Unexplained complaints (UCs) have been defined as
complaints of which the origins remain unclear to
a GP after adequate history taking, physical
examination and careful consideration of the psycho-
social context.1 On average, 13% of GP consultations
involve UCs.2 It is often assumed that most of the
(medical) problems that give rise to newly presented
UCs are self-limiting because patients often do not
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revisit their GPs on account of that specific UC.3–5 For
example, Kroenke et al. found that 90% of UC pa-
tients did not revisit their GPs within 1 month.
Newly presented UCs may be a sign of underlying
somatic or psychosocial pathology. Furthermore, they
may remain unexplained and may be transformed into
what may then be called persistent(ly) UCs to empha-
size that the complaints as well as the inexplicability
continue. In the literature, percentages of patients for
whom these complaints are the reason to consult their
GPs, vary from 3 to 39%.6 Patients with persistent
UCs (also called MUS for medically unexplained
symptoms) often use many drugs and other health
care facilities and frequently show considerable psy-
chological distress.7,8 Furthermore, persistent UCs are
associated with a low quality of life (QoL).9 Moreover,
as these patients often do not feel taken seriously or
helped and sometimes feel treated as malingerers,
they tend to lose trust in their GPs.10
So far, the transition of newly presented UCs into
persistent UCs and its risk factors have scarcely been
investigated although a better understanding of the
mechanisms involved may eventually lead to better
prevention. Our objectives were to find how many
and what type of diagnoses are made within 1 year af-
ter first presentation of a UC, which proportion of
newly presented UCs persist, and to identify factors
associated with becoming persistent. Finally, we longi-
tudinally studied risk factors of poor QoL.
Materials and Methods
General design
Between February 2002 and December 2003, GPs
from the southern and the western parts of The Neth-
erlands recruited patients for a prospective 12-month
follow-up cohort study on newly presented UCs. The
Medical Ethics Committees of the University of Am-
sterdam and Maastricht University approved the study
protocol. The study was part of a randomized trial on
the value of blood test ordering for patients with
UCs.11,12
Patients and complaints
GPs included patients >18 years of age, presenting
with a new complaint that the GP designated as ‘unex-
plained’ at the end of the first consultation. GPs were
given the Dutch College of General Practitioners’ def-
inition of UCs: those complaints that remain of un-
clear origin to the GP after adequate history taking,
physical examination and careful consideration of the
patient’s psychosocial context. Eligible were UCs that
concerned fatigue, abdominal complaints, musculo-
skeletal complaints, weight changes or itch. A UC was
called new if it had not been presented to the GP
within the 6 months prior to the visit. Patients were
instructed to revisit their GPs when their complaints
had not resolved after 4 weeks. Each patient presented
no more than a single UC. Patients gave written
informed consent after having read the study informa-
tion at home. They received this information from
their GPs after the first consultation and returned it
by mail.
Measurements
GPs filled out structured case record forms (CRFs)
immediately after the entry consultation and again
when patients revisited with the same complaint after
4 weeks as instructed. CRFs included detailed ques-
tions about the history, such as type of complaint, du-
ration of complaint or symptoms, findings on physical
examination (if performed) and some general ques-
tions about how the GP appraised the consultation
[degree to which s/he felt the complaint was unex-
plained, degree of certainty about the absence of seri-
ous disease, (certainty about) working hypothesis and
his/her satisfaction]. After the entry consultation (T0),
patients were given a patient questionnaire enquiring
after demographic characteristics, intensity of com-
plaints, satisfaction with care, anxiety, QoL and health
care utilization. Patients filled out the same question-
naires at 4–6 weeks (T1), 6 months (T6) and 12 (T12)
months. These follow-up questionnaires included
a question on the presence of the complaint.
Generic health-related QoL was measured by
means of the RAND-36. The RAND-3613 is a Dutch
version of the SF-3614 and consists of 36 questions
and standardized response choices, organized into
eight multi-item domains: physical functioning, role
limitations due to physical health problems, social
functioning, general mental health, role limitations
due to emotional problems, vitality, bodily pain and
general health perception. Domain scores may vary
from 0 to 100 (where 0 indicates ‘very poor’ and 100
‘excellent’). From the eight RAND-36 domains, sum-
mary physical component scale (PCS) and mental
component scale (MCS) were constructed.15 The
EuroQol’s thermometer was assessed as a proxy for
QoL as well. The thermometer provides a single index
value (0–100) for health status.16
At 12 months, electronic medical records (EMRs)
were retrospectively searched for all complaint-related
entries such as diagnoses, working hypotheses and
complaint level evaluations in the previous year. The
final categorization of the complaints was carried out
in three steps. First, two of the authors (HK and
MAvB) independently searched the EMRs for all
complaint-related GP entries and summarized these
into one diagnosis per patient. To obtain a single diag-
nosis, we first individually gathered a maximum of
three complaint-related entries throughout the year
and from these selected the one that seemed most im-
portant. Discordances were resolved by discussion.
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Unresolved discordances were settled by one of two
experienced GPs (PJEB and GJD). Second, these di-
agnoses were categorized in ‘complaint not otherwise
specified’ (e.g. fatigue and abdominal complaints; final
evaluation identical to initial complaint), ‘psychosocial
illness’ (e.g. depression and burn out), ‘somatic illness’
(e.g. diabetes mellitus and hypothyroidism),
‘syndrome’ (e.g. irritable bowel syndrome and chronic
fatigue syndrome) or ‘otherwise’ (for all evaluations
in the EMR with a question mark or listings of differ-
ential diagnoses). In this step, discordances were
resolved as described above. Finally, the categories
‘complaint not otherwise specified’ and ‘otherwise’
were collapsed into ‘unexplained’, whereas the
psychosocial illness, somatic illness and syndrome cat-
egories were collapsed into ‘explained’.
Statistical analysis
We summarized the diagnoses made and course of
complaints over time. We assessed determinants of (i)
the probability that the initial complaint was still un-
explained and present at 12 months; (ii) the longitudi-
nal course of the initial complaint at 1, 6 and 12
months, regardless of whether it became explained
and (iii) the longitudinal course of the QoL, separately
for summary scales PCS and MCS of the RAND-36.
Table 1 shows which risk factors were assessed for
each of these analyses.
To study the effect of potential risk factors, we used
longitudinal maximum likelihood mixed-effect logistic
and linear regression analysis with complaint present
‘yes/no’ and RAND-36 PCS or RAND-36 MCS as the
dependent variables, respectively. Prior to these, we
familiarized ourselves with the data using dedicated
descriptive commands for longitudinal data and line
graphs to study the unadjusted course of the depen-
dent variables over time or after stratification for sin-
gle determinants (see Fig. 1 for an example). In the
longitudinal analyses, the time variable had the values
1, 6 and 12 for the follow-up times at 1, 6 and
12 months, respectively.
Missing data were multiply (m = 10) imputed using
iterative chained equations. Briefly, for each variable
in turn missing values are filled in with randomly
chosen observed values. Then, ‘filled-in’ values in the
first variable are removed, leaving the original missing
values. These missing values are then imputed using
regression imputation on all other variables. Next, the
filled-in values in the second variable are removed.
These missing values are then imputed using regression
imputation on all other variables. This process is re-
peated for each variable. Once each variable has been
TABLE 1 Potential determinants used in the models
Determinant Source Answer categories Used in
Model 1 Model 2 Model 3
Patient’s age CRF/PQ Years x x x
Patient’s sex CRF/PQ Male/female x x x
Type of complaint CRF Fatigue/abdominal/
musculoskeletal
x x x
Duration of complaints before presentation CRF Less/more than 4 weeks x x x
Patient’s perception of complaint intensity PQ Bearable/unbearable x x x
RAND-36 PCS at inclusion PQ 0 through 100 x x
RAND-36 MCS at inclusion PQ 0 through 100 x x
EuroQol’s thermometer at inclusion PQ 0 through 100 x x x
Intensity of complaints according to GP CRF Bearable/unbearable x x x
Presence of psychosocial factors CRF Present/absent x x x
Presence of previous episodes CRF Present or absent/unknown x x x
Performance of physical examination CRF Yes/no x x x
Presence of abnormal findings on physical
examination
CRF Yes/no x x x
Degree to which complaint is unexplained CRF 0 (totally unexplained) to 6 (a little
unexplained)
x x x
GP’s certainty on absence of serious disease CRF 0 (totally uncertain) to 6
(totally certain)
x x x
GP’s certainty on working hypothesis CRF 0 (totally uncertain) to 6 (totally certain) x x x
GP’s satisfaction with the consultation CRF 0 (very dissatisfied) to 10 (very satisfied) x x x
Diagnosis made within 12 months EMR Yes/no x x x
Time CRF/PQ 0 (baseline); 1 (1 mo ab); 6 (6 mos ab); 12
(12 mos ab)
x x x
Intervention arm Immediate BTO/postponement of BTO x x x
Model 1: assess determinants of probability that, 12 months after baseline, the initial complaint was still unexplained and present. Model 2:
assess determinants of the longitudinal course of the main complaint (regardless whether it became explained or remained unexplained). Model
3: assess determinants of the longitudinal course of the QoL. PQ, patient questionnaire; BTO, blood test ordering; mo(s), month(s); ab, after
baseline.
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imputed, we have completed one ‘cycle’. The process is
continued for 10 cycles.17 Before imputation, we
changed the ‘long’ data file format into a ‘wide’ format
to ensure that one patient had one record while imput-
ing, as recommended by Allison.18–20 After imputation,
the long data format needed for longitudinal analyses
was restored.
Multiple imputation assumes that the mechanisms
responsible for the missing values are captured with
the variables available in the dataset,21 the so-called
missing-at-random (MAR) assumption. In accordance
with the advice to use a rich model for imputation, we
used 29 variables for imputation—seven patient-
reported variables: sex, age, complaint type, duration
of complaints at baseline, patients’ perception of com-
plaint intensity, presence of previous episodes, Euro-
Qol’s thermometer at inclusion; eight GP-reported
variables: performance of physical examination, pres-
ence of abnormal findings at physical examination,
degree to which the complaint was unexplained, cer-
tainty on absence of serious disease, certainty on
working hypothesis, satisfaction with the consultation,
perception of complaint intensity, presence of psycho-
social factors; two EMR-based variables: group assign-
ment in randomized trial, whether a diagnosis had
been made within 12 months; nine outcome variables
and the three time indicators. The MAR assumption
is far weaker than its missing completely at random
counterpart, which assumes that the missing data are
a random sample of all data. For each patient, the
number of missing values on time-independent covari-
ates ranged between 0 and 12 (median number 0;
p10 = 0; p90 = 4.5). In total, 541 missing values were
imputed out of 5328 values (10%) (444 patients  12
time-independent covariates).
We assessed the differences between those with
complete and incomplete data using a logistic regres-
sion model (incomplete coded as 1 and complete as 0)
with baseline variables as predictors. Under the null
hypothesis of no differences between these groups,
the odds ratios (ORs) associated with the predictors
should be not significantly different from unity. We
studied the relationships between continuous predic-
tors and the dependent variables using scatter plots of
locally weighted regressions (lowess plots) to check
linearity assumptions and avoid model misspecifica-
tion. We chose not to impute missing values on depen-
dent variables in accordance with recommendations
from the statistical literature.22,23 However, dependent
variables were used to impute missing values on the
independent variables.24
The final regression models were fit using the Li–
Raghunathan–Rubin formula to estimate the mean
coefficients and the correct variance across the 10 im-
puted sets.19,20 Likelihood ratio (chunk) tests
(P < 0.05) were used to reduce the models including
all predictors to leaner models25 provided that the re-
gression coefficients of the variables remaining in the
model did not change by >10%.26 This was also ap-
plied to decide on the necessity to keep the 63 GPs as
random intercepts; the random intercepts for patients
were always retained. Random slopes were not consid-
ered since we deemed the theory in this field of re-
search insufficient to underpin potential random
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FIGURE 1 Line graph showing the (unadjusted) course of
mean QoL [physical (left y-axis) and mental (right y-axis)]
over 12 months. Note that after an initial and modest rise
between baseline and 1 month, the mean QoL scores remain
stable and fairly low in all subgroups. At baseline all
complaints are unexplained. Note that the GP finding an
apparent explanation for the initial complaint during the
12-month follow-up had no clear impact on the QoL
differences that were already present between the groups at
baseline for PCS andMCS, respectively; this was confirmed in
the multivariable analysis. MCS unexplained/explained, mean
MCS scores of patients with newly presented UCs that
remained unexplained/became explained over time; PCS
unexplained/explained, mean PCS scores of patients with
newly presented UCs that remained unexplained/became
explained over time.
TABLE 2 Background characteristics (N = 444).
Median age in years
(p10, p25, p75, p90)
42.3 (22.2, 30.6, 53.5, 66.5)
n (%)
Complaint group
Fatigue 308 (69)
Abdominal 63 (14)
Musculoskeletal 73 (17)
Sex
Male 119 (27)
Female 325 (73)
Highest educational level
None 3 (1)
Elementary 35 (8)
Secondary 287 (65)
Higher 93 (21)
Missing 26 (6)
p, percentile; e.g. p10 means that 10% of the patients were <22.2 years
old.
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slopes with good explanations. We considered P-val-
ues <0.05 as statistically significant. All analyses were
performed using Stata software (College Station, TX,
version 10.1).
Results
Study population
In total, 63 GPs in 57 practices included 513 patients
with newly presented UCs. The median number of
included patients per GP was 6 (interquartile range 3–
10). We excluded the complaint categories for which
few patients were included (weight changes, n = 27;
itch, n = 18) to avoid the impression that our findings
could be generalized to cover these poorly represented
complaints. This left 467 patients with newly presented
unexplained fatigue (n = 324), abdominal (n = 66) or
musculoskeletal (n = 77) complaints. Twenty-three of
these dropped out because of moving house or for
other personal reasons. The background characteris-
tics of the remaining 444 patients are presented in -
Table 2. Patient classification in terms of complaint-
related diagnoses/evaluations and presence of com-
plaints 12 months after baseline are presented in Figure
2. Logistic regression analysis showed that no baseline
467 (total number of analysable patients) 
23 drop-outs 
444 
Became explained 
175 (40%) 
Missing EMR 
15 (3%) 
Remained unexplained 
254 (57%) 
Psychosocial: 68 (15% of 444) 
-surmenage/stress 18 (26%) 
-depression 14 (21%) 
-functional 8 (12%) 
-relational problems 6 (9%) 
-anxiety 5 (7%) 
-somatisation 4 (6%) 
-various 13 (20%) 
Somatic: 82 (18% of 444) 
-infection/inflammation 18 (22%) 
-arthrosis/degenerative 11 (13%) 
-diabetes mellitus 7 (9%) 
-anaemia 5 (6%) 
-hypothyreoidism 3 (4%) 
-infectious mononucleosis 3 (4%) 
-various 34 (41%) 
Syndrome: 25 (6% of 444) 
-IBS 16 (64%) 
-CFS/fibromyalgia 5 (20%) 
-various 4 (16%) 
Still/again complaints at T12 
84 (48%)
No complaints at T12 
58 (33%)
Missing complaint status 
33 (19%)
Missing complaint status 
43 (17%)
No complaints at T12 
102 (40%)
Still/again complaints at T12 
109 (43%)
EMR: electronic medical registration 
IBS: irritable bowel syndrome 
CFS: chronic fatigue syndrome 
T12: 12 months after inclusion 
FIGURE 2 Patient classification in terms of complaint-related diagnoses or evaluations and the presence or absence of complaints
12 months after inclusion.
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variables were associated with whether data for a pa-
tient were complete. Table 3 shows a comparison be-
tween patients with complete data and those with at
least one missing value for age, sex and complaint
group. Table 4 shows that the distributions of the
observed values were very similar to those after
imputation.
Complaint-related diagnoses/evaluations
In total, 254 [57%; 95% confidence interval (CI) from
53 to 62] of the newly presented UCs remained unex-
plained after 1 year. Out of 175 (39%; 95% CI 35 to
44) newly presented UCs that became explained dur-
ing the 12-month follow-up, 82 explanations were of
somatic origin (18% of the total of 444; 95% CI
15–22) and 68 of psychosocial origin (15% of 444;
95% CI 12–18). Overall, in 15 (3%; 95% CI 2 to 6) pa-
tients, data from the EMRs were missing. Figure 2
shows complaint-related diagnoses made within the
psychosocial, somatic and syndrome categories.
Presence/absence of complaints over time
Regardless of whether their complaints became ex-
plained or not, 193 of 444 patients (44%; 95% CI
39–48) with newly presented UCs claimed that they
suffered from these complaints at 12 months. This was
the case in 109/254 (43%; 95% CI 37–49) patients with
complaints that remained unexplained and 84/175
(48%; 95% CI 41–55) of patients with complaints that
became explained during the follow-up. In 120/444
patients (27%; 95% CI 23–31), the complaints were
present at all four times points. Forty-eight patients
(11% of 444; 95% CI 8–14) complained only at inclu-
sion. In total, 276 patients (62% of 444; 95% CI
58–67) had variable patterns of presence/absence of
complaints at 1, 6 and 12 months.
Determinants of the course of complaints and QoL
There were four time points for follow-up, implying
1776 (4  444) potential observations. Since some de-
pendent variables were missing, the number of obser-
vations in the regression models varied. The final
models are based on a minimum of 1426 (81%) to
1628 (92%) observations. Full and lean models are
presented in Tables 5, 6, 7 and 8.
Four predictors were found of the probability of
newly presented UCs remaining unexplained and pres-
ent at 12 months. Being a male (OR 0.6; 95% CI
0.4–0.8), having abdominal complaints (OR 0.5; 95%
CI 0.3–0.8), the GP’s perception of the complaint in-
tensity being unbearable (OR 0.4; 95% CI 0.2–0.7)
and GPs being more certain about the absence of seri-
ous disease (OR 0.9 per point higher on the scale;
95% CI 0.8–0.99) all diminished the probability that
12 months after baseline, the complaint would still be
unexplained and present. Table 5 shows the OR and
95% CI of all determinants in the model.
Strong predictors of the probability that complaints
continued to be present over time were as follows:
having musculoskeletal complaints (OR 2.3; 95% CI
1.2–4.5), >4 weeks duration of the complaint before
first presentation (OR 2.6; 95% CI 1.6–4.3), the MCS
of the RAND-36 at presentation (OR 0.95 per point
higher on the scale; 95% CI 0.93–0.97), the PCS
of the RAND-36 at presentation (OR 0.9 per point
higher on the scale; 95% CI 0.88–0.92), presence of
TABLE 3 Comparison of age, sex and complaint group for patients
with complete data (n = 190) and those with at least one missing value
(n = 254)
Complete
cases (n = 190)
Incomplete
cases (n = 254)
Age (SD) 44.4 (14.81) 42.7 (16.54)
Sex (male, %) 26.8 26.8
Complaint group (%)
Fatigue 72.6 66.9
Abdominal complaints 14.7 13.8
Muscle and joint 12.6 19.3
In total, 190/444 (42.8%) of all patients had complete data; 254/444
(57.2%) had at least one missing value. The median number of miss-
ing values in the latter group was 6 (interquartile range from 2 to 13).
TABLE 4 Distributions of variables as observed and after multiple (10-fold) imputation
Variable Observed Imputed (n = 4440)
Duration of complaint before presentation >4 weeks (%) 76.1 (n = 402) 76.2
Patient’s perception of complaint intensity as unbearable (%) 25.3 (n = 384) 25.8
EuroQol’s thermometer at inclusion, mean (SD) 58.9 (19.11) (n = 425) 58.8 (19.15)
Intensity of complaints unbearable according to GP 9.0 (n = 389) 10.6
Presence of psychosocial factors (%) 36.5 (n = 395) 36.2
Presence of previous episodes (%) 27.3 (n = 406) 27.4
Performance of physical examination (%) 72.7 (n = 406) 72.5
Presence of abnormal findings at physical examination (%) 20.7 (n = 406) 21.8
Degree to which complaint is unexplained, mean (SD) 3.69 (1.80) (n = 397) 3.68 (1.83)
GP’s certainty on absence of serious disease, mean (SD) 5.61 (1.31) (n = 394) 5.57 (1.32)
GP’s certainty on working hypothesis, mean (SD) 5.39 (1.32) (n = 385) 5.35 (1.35)
GP’s satisfaction with the consultation, mean (SD) 7.29 (1.50) (n = 398) 7.27 (1.52)
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previous episodes >6 months prior to presentation
(OR 2; 95% CI 1.2–3.4), passage of time (OR 0.81;
95% CI 0.8–0.84) and the GP documenting an expla-
nation for the complaint (OR 0.5; 95% CI 0.3–0.8)
(Table 6).
Longitudinal analysis showed that musculoskeletal
complaints (–4.6; 95% CI –6.7 to –2.6), presence of
psychosocial factors (OR 2; 95% CI 0.5–3.5), previous
episodes of the same complaints >6 months prior to
presentation (–2; 95% CI –3.7 to –0.4) and age (–0.09
per year; 95% CI –0.1 to –0.05) negatively influenced
the course of physical QoL. Passage of time (0.3; 95%
CI 0.2–0.4), the GP documenting an explanation for
the complaint (OR 1.1; 95% CI 0.06–2.2) and the
EuroQol thermometer score at presentation (0.1 for
each point; 95% CI 0.08–0.2) positively influenced this
course (Table 7).
Previous episodes of the same complaints >6
months before presentation (–2.8; 95% CI –4.9 to
–0.7) and the presence of psychosocial factors (–5;
95% CI –6.9 to –3.1) negatively influenced the course
of mental QoL. Musculoskeletal complaints (5.5; 95%
CI 3–7.9) in comparison to being tired (fatigue), pas-
sage of time (0.4; 95% CI 0.3–0.5) and the EuroQol
thermometer score at presentation (0.2 for each point;
95% CI 0.1–0.21) positively influenced this course
(Table 8).
Discussion
In this prospective cohort study among patients with
newly presented UCs in general practice, we found that
43% suffers from these complaints 12 months after ini-
tial presentation. Overall, almost 60% of newly pre-
sented UCs remained unexplained during 1 year. In
many patients, UCs followed a varying pattern of pres-
ence and absence. About 40% of UCs received an
explanation. Male sex, abdominal complaints, as com-
pared to fatigue, and increased GPs’ certainty about the
absence of serious disease diminished the probability
that the complaints would be unexplained and still pres-
ent after a year. Longer duration of the complaint be-
fore presentation was associated with lower probability
of it resolving, regardless of it remaining unexplained.
Obviously, first presentation of a problem to the GP
does not necessarily imply that this problem is new to
the patient. Patients with new UCs tended to have
a poor QoL; we found no strong determinants of varia-
tion in this course. Especially musculoskeletal com-
plaints and previous episodes of the same complaints
were associated with a negative course of the QoL on
the physical dimension. The course of the mental sum-
mary scale of QoL was negatively influenced by fatigue,
previous episodes of the same complaints and the pres-
ence of psychosocial problems.
TABLE 5 Determinants of probability that, 12 months after baseline, the initial complaint was still unexplained and present
Determinant (reference value) Full model Lean model
OR (95% CI) OR (95% CI)
Patient’s age (1 year older) 1.00 (0.99 to 1.01)
Patient’s sex (male) 0.48 (0.32 to 0.71) 0.60 (0.43 to 0.83)
Type of complaint
Fatigue (reference category) 1 (n.a.) 1 (n.a.)
Abdominal complaints 0.51 (0.29 to 0.88) 0.54 (0.34 to 0.84)
Musculoskeletal complaints 0.75 (0.44 to 1.27) 1.20 (0.81 to 1.76)
Duration of complaints before presentation (over 4 weeks) 1.03 (0.69 to 1.53)
Patient’s perception of complaint intensity (unbearable) 0.86 (0.54 to 1.37)
RAND-36 PCS at inclusion (1 point higher) 1.00 (0.98 to 1.02)
RAND-36 MCS at inclusion (1 point higher) 1.00 (0.98 to 1.02)
EuroQol’s thermometer at inclusion (1 point higher) 0.99 (0.98 to 1.00)
GP’s perception of complaint intensity (unbearable) 0.38 (0.18 to 0.78) 0.39 (0.22 to 0.71)
Presence of psychosocial factors (yes) 1.16 (0.80 to 1.68)
Presence of previous episodes (yes) 0.94 (0.65 to 1.36)
Performance of physical examination (yes) 0.83 (0.56 to 1.23)
Presence of abnormal findings on physical examination (yes) 0.86 (0.55 to 1.35)
Degree to which complaint is unexplained (1 point less
unexplained)
1.09 (0.97 to 1.22)
GP’s certainty on absence of serious disease (1 point more certain) 0.77 (0.66 to 0.90) 0.88 (0.78 to 0.99)
GP’s certainty on working hypothesis (1 point more certain) 1.06 (0.90 to 1.23)
GP’s satisfaction with the consultation (1 point more satisfied) 1.10 (0.96 to 1.25)
Intervention arm (immediate BTO) 1.02 (0.31 to 3.33)
Time (1 measurement time further) n.a.
Establishment of explanation (diagnosis/evaluation) (yes) n.a.
Lean model’s variance:
Variance at GP level 9.07 (3.03 to 80.11)
BTO, blood test ordering; n.a., not applicable.
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Little research on the course of UCs and their de-
terminants has been performed so far. A recently pub-
lished systematic review by Olde Hartman et al.27
concludes that due to the limited numbers of studies
and their heterogeneity, there is a lack of rigorous em-
pirical evidence to identify relevant prognostic factors
in patients presenting persistent medically unex-
plained symptoms (MUS). They also conclude that it
seems that a more serious condition at baseline is as-
sociated with a worse outcome. When ‘longer duration
of complaints before presentation’ and ‘having had
previous episodes of the same complaints’ are consid-
ered as a ‘more serious condition at baseline’, this fits
in with our findings that a longer duration of com-
plaints before presentation is associated with a poorer
prognosis of complaint duration and that having had
previous episodes of a complaint negatively influences
the course of the QoL.
Some limitations in our study deserve attention.
First of all, inclusion may not have been consecutive.
Sixty-three participating GPs identified between 3 and
10 patients with newly presented UCs each during
a 23-month period. Based on earlier studies, we sus-
pect that they must have seen many more patients
with UCs. In a non-inclusion study in the participating
general practices, we searched the electronic medical
files by means of text words for eligible but not-
included patients with UCs. This study did not show
major sex and age differences between included
(n = 513) and not-included (n = 507) patients. How-
ever, differences may exist on other characteristics
and this may limit the generalizability of our findings.
To clarify, complete non-selection of, for example,
men simply limits the formal generalizability of our
findings to women. In reality, opinion on scientific gen-
eralizability, as opposed to statistical, may vary with
opinions on the importance of sex as an effect modifier
of the associations reported. So selection as such
should be distinguished from selection bias, which has
been defined as conditioning on factor that is affected
by a determinant of interest and by the outcome.28 If
non-selection is only partial, for example, if some pa-
tients with fatigue were excluded, incorporation of
fatigue in the regression model (through the complaint
group variable) deals with this issue by adjusting for
fatigue. Residual confounding is possible since the pre-
dictors on psychosocial problems and single items of
the SF-36 (mental scale) may not have captured full
information on anxiety, depression and self-efficacy.
We showed that UCs are not as frequently self-
limiting as is sometimes assumed. Whereas Kroenke
and Jackson5 and Kenter et al.3, for example, found
that 90% of UCs are self-limiting, we found that >40%
of patients experience their UCs after 1 year. One
TABLE 6 Determinants of an unfavourable longitudinal course of the initial complaint in terms of presence of complaints (regardless whether they
were explained or remained unexplained)
Determinant (reference value) Full model Lean model
OR (95% CI) OR (95% CI)
Patient’s age (1 year older) 0.99 (0.97 to 1.00)
Patient’s sex (male) 1.08 (0.65 to 1.81)
Type of complaint
Fatigue (reference category) 1 (n.a.) 1 (n.a.)
Abdominal complaints 1.73 (0.88 to 3.40) 1.67 (0.88 to 3.15)
Musculoskeletal complaints 2.44 (1.16 to 5.13) 2.29 (1.16 to 4.51)
Duration of complaints before presentation (over 4 weeks) 2.56 (1.52 to 4.34) 2.62 (1.59 to 4.33)
Patients perception of complaint intensity (unbearable) 1.12 (0.60 to 2.08)
RAND-36 PCS at inclusion (1 point higher) 0.89 (0.86 to 0.93) 0.90 (0.88 to 0.92)
RAND-36 MCS at inclusion (1 point higher) 0.94 (0.92 to 0.97) 0.95 (0.93 to 0.97)
EuroQol’s thermometer at inclusion (1 point higher) 1.01 (1.00 to 1.02)
GP’s perception of complaint intensity (unbearable) 0.95 (0.36 to 2.48)
Presence of psychosocial factors (yes) 1.22 (0.73 to 2.04)
Presence of previous episodes (yes) 1.95 (1.14 to 3.34) 2.04 (1.21 to 3.43)
Performance of physical examination (yes) 0.86 (0.51 to 1.46)
Presence of abnormal findings on physical examination (yes) 1.10 (0.59 to 2.05)
Degree to which complaint is unexplained (1 point less unexplained) 0.96 (0.84 to 1.10)
GP’s certainty about absence of serious disease (1 point more certain) 0.90 (0.73 to 1.11)
GP’s certainty about working hypothesis (1 point more certain) 1.03 (0.85 to 1.25)
GP’s satisfaction with the consultation (1 point more satisfied) 0.97 (0.82 to 1.14)
Intervention arm (immediate BTO) 0.96 (0.56 to 1.65)
Time (1 measurement time further) 0.81 (0.78 to 0.84) 0.81 (0.78 to 0.84)
Establishment of explanation (diagnosis/evaluation) (yes) 0.50 (0.31 to 0.80) 0.50 (0.31 to 0.80)
Lean model’s variance:
Variance at GP level 1.29 (1.06 to 2.89)
Residual error 4.17 (2.29 to 11.65)
BTO, blood test ordering; n.a., not applicable.
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explanation for this difference might be that the other
studies consider complaints to be resolved when pa-
tients do not revisit their GP with the same complaints.
Our findings were based on patient questionnaires on
top of the EMR entries. Other data from our study
show that patients do not frequently revisit their GP
for their UCs, but when asked personally after 1 year,
>40% of them reported to perceive complaints.
In the group of patients with established explained
complaints, there are patients with somatic diagnoses
of chronic diseases, such as diabetes mellitus and ar-
throsis. A small fraction of this group stated not to suf-
fer from their complaints after 12 months. This may be
an effect of their treatment. When treated properly,
patients with diabetes mellitus may no longer suffer
from fatigue, for example. Our data did not allow un-
ambiguous analysis of the role of treatment effects.
We chose to categorize syndrome-type diagnoses
(chronic fatigue syndrome, irritable bowel syndrome
etc.) as ‘explained complaints’. Moreover, the few so-
matoform disorder diagnoses were categorized as ‘ex-
plained’. Had we categorized these diagnoses as
‘unexplained’, the percentage of persistently UCs
would have been even higher (64% instead of 57%).
Surprisingly, if the GP perceived the complaints as
being unbearable to the patient, this diminished the
chance of the complaints being present and unex-
plained after 12 months. We do not have a plausible
explanation for this finding and replication in future
studies seems warranted.
Our study sheds some light on the transition of
newly presented to persistent UCs and on determi-
nants of the course of complaints and QoL. A com-
plaint’s duration of >4 weeks before presentation
appears to signal a lower probability that the com-
plaints will resolve, as do poor perceived physical and
mental well-being. If a diagnosis is made, the probabil-
ity that the complaint will resolve increases, perhaps
as a consequence of the treatment. The simple passing
of time also has a beneficial effect. The few determi-
nants influencing the QoL were relatively weak and
their potential to change the unfavourable course ap-
pears limited.
In our opinion, our findings should stimulate GPs to
take UCs more seriously as from their initial presenta-
tion. Paying attention to the determinants we found
may be helpful in detection of patients with an unfav-
ourable course of complaints and QoL among the pa-
tients with newly presented UCs in general practice.
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TABLE 7 Determinants of an unfavourable longitudinal course of the physical QoL in terms of lower scores on the summary scales
Determinant (reference value) Full model Lean model
Coefficient (95% CI) Coefficient (95% CI)
Patient’s age (1 year older) –0.09 (–0.14 to –0.04) –0.10 (–0.14 to –0.05)
Patient’s sex (male) 0.002 (–1.70 to 1.70)
Type of complaint
Fatigue (reference category) 1 (n.a.) 1 (n.a.)
Abdominal complaints –1.41 (–2.58 to 2.30) 0.39 (–1.80 to 2.59)
Musculoskeletal complaints –4.55 (–6.89 to –2.22) –4.65 (–6.70 to –2.60)
Duration of complaints before presentation (over 4 weeks) –1.40 (–3.23 to 0.44)
Patient’s perception of complaint intensity (unbearable) –1.04 (–3.09 to 1.01)
RAND-36 PCS at inclusion (1 point higher) n.a. n.a.
RAND-36 MCS at inclusion (1 point higher) n.a. n.a.
EuroQol’s thermometer at inclusion (1 point higher) 0.12 (0.08 to 0.17) 0.13 (0.08 to 0.17)
GPs’ perception of complaint intensity (unbearable) 0.98 (–2.11 to 4.07)
Presence of psychosocial factors (yes) 1.80 (0.14 to 3.46) 1.96 (0.45 to 3.46)
Presence of previous episodes (yes) –1.98 (–3.71 to –0.26) –2.04 (–3.71 to –0.38)
Performance of physical examination (yes) 0.93 (–0.88 to 2.74)
Presence of abnormal findings on physical examination (yes) –1.22 (–3.36 to 0.93)
Degree to which complaint is unexplained (1 point less unexplained) 0.12 (–0.35 to 0.60)
GPs’ certainty on absence of serious disease (1 point more certain) 0.35 (–0.36 to 1.06)
GPs’ certainty on working hypothesis (1 point more certain) –0.32 (–1.00 to 0.36)
GPs’ satisfaction with the consultation (1 point more satisfied) 0.14 (–0.39 to 0.67)
Intervention arm (immediate BTO) –0.62 (–2.45 to 1.20)
Time (1 measurement time further) 0.29 (0.21 to 0.36) 0.29 (0.22 to 0.36)
Establishment of explanation (diagnosis/evaluation) (yes) 1.13 (0.03 to 2.22) 1.11 (0.06 to 2.16)
Lean model’s variance:
Variance at GP level 1.48 (1.00 to 4.60)
Variance at pt level 30.97 (22.25 to 43.85)
Residual error 19.01 (16.37 to 22.16)
BTO, blood test ordering; n.a., not applicable; pt, patient.
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